Ahli urologi bersertifikat yang berspesialisasi dalam bedah invasif minimal dan prosedur rekonstruktif di Menness Wellness Clinic.
Dr. Ilker Tinay berspesialisasi dalam onkologi urologi dengan fokus pada bedah invasif minimal dan rekonstruksi neobladder di Anadolu Medical Center.
Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center, dengan spesialisasi dalam kasus tumor kompleks.
Telah melakukan lebih dari 2000 operasi hepatobilier dengan tingkat keberhasilan 95% – Profesor Aliosmanoglu memimpin Unit Transplantasi Organ di Medical Park Antalya.
Spesialis onkologi urologi dengan pengalaman lebih dari satu dekade dalam pengangkatan tumor testis – Dr. Tsafrakidis berpraktik di German Oncology Centre di Siprus.
Dr. Barak Rosenzweig memimpin Layanan Onkologi Urologi di Sheba Medical Center di Israel. Beliau adalah seorang ahli bedah yang terdaftar di antara Dokter Terbaik Israel oleh Forbes. Dr. Rosenzweig berspesialisasi dalam mengobati tumor prostat, ginjal, kandung kemih, dan testis. Beliau berfokus pada bedah kanker robotik dan invasif minimal untuk menjaga fungsi organ.
Dr. Solak berspesialisasi dalam pengobatan kanker testis dengan pelatihan fellowship di Hacettepe University Cancer Institute.
Dr. Xavier Centeno Fornies menjalani pelatihan di Mayo Clinic yang bergengsi dalam bedah kolorektal dan memimpin departemen bedah di Centro Médico Teknon.
Kepala Dokter di pusat kanker interdisipliner bersertifikat di Solingen, Dr. Viola Fox berspesialisasi dalam hematologi, onkologi, dan perawatan paliatif.
Profesor Madya Tahsin Ozatli berspesialisasi dalam pengobatan kanker payudara, paru-paru, dan saluran pencernaan di Rumah Sakit Universitas Istinye Liv.
Dr. Alemdar berspesialisasi dalam onkologi medis dengan pelatihan ekstensif di Universitas Akdeniz dan pengalaman dalam kanker urologi.
Dr. Nir Kleinmann memimpin Unit Endourologi dan Batu Ginjal di Sheba Medical Center. Beliau adalah pelopor dalam bedah laser hemat ginjal untuk tumor kompleks. Forbes dan ResultMed menobatkannya sebagai salah satu Dokter Terbaik Israel untuk tahun 2025 dan 2026. Dr. Kleinmann menggunakan sistem laser ganda yang unik untuk menjaga fungsi organ selama perawatan kanker.
Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.
1980–1985: Completed doctoral studies at Nagasaki University, Japan
1968–present: Department of Radiology, Chinese PLA General Hospital
1988: Third Prize of the Military Science and Technology Progress Award
1989–present: Member of Radiological Society of North America(RSNA)
1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA
1991: Second Prize of the Military Science and Technology Progress Award
1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology
1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
1993: Granted the Lifetime Special Government Allowance of the State Council
1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology
1994: Third Prize of the Military Science and Technology Progress Award
1997: Second Prize of the Military Science and Technology Progress Award
1997–2009: Standing Member of Chinese Society of Radiology
1999: Third Prize of the Military Science and Technology Progress Award
1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology
2002: Second Prize of the Military Science and Technology Progress Award
2005: Third Prize of the Military Science and Technology Progress Award
Member of Radiological Society of North America(RSNA)
Standing Member of Chinese Society of Radiology
Group Leader of the Group of Intervention of Chinese Journal of Radiology
Deputy Director Member of Chinese Society of Interventional Oncology
Director Member of Beijing Medical Association Society of Interventional Radiology
Deputy Chief Editor of Chinese Journal of Medical Image Technology
Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army
Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology
Awarded the Special Government Allowance of the State Council
Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.
Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”
Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.
In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.
Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.
In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.
Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.
From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.
Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.
1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.
Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.
2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.
Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.
3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.
Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.
4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.
Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.
5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.
Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.
6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.
Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.
7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.
Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.
8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.
Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.
1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.
2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.
3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.
1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.
2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.
3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.
4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.
Dr. Cevper Ersoz berspesialisasi dalam bedah robotik dan laparoskopi untuk kanker urologi, termasuk tumor testis, di Medipol Acibadem District Hospital.
Spesialis dalam bedah urologi, termasuk kasus kompleks – Dr. Bogdan memberikan perawatan ahli di Dievo Surgery Center.
Dr. Caterina Lania berspesialisasi dalam patologi urogenital pria, termasuk tumor testis, dengan pengalaman penelitian dan klinis yang luas di Rumah Sakit San Raffaele.
Dr. Orhan Ünal Zorba, profesor asosiasi, adalah seorang ahli urologi yang berfokus pada andrologi dan endourologi. Beliau memiliki pengalaman sekitar 25 tahun. Saat ini, beliau menangani pasien di Rumah Sakit Swasta TUSA. Beliau mulai bekerja di sana pada 8 Juni 2026.
Karya akademis beliau mencakup 29 publikasi internasional, 13 publikasi nasional, dan 7 bab buku. Beliau telah memberikan setidaknya 9 presentasi di kongres internasional. Studi beliau telah dipresentasikan pada pertemuan EAU, ESSM, ICS, dan EULIS. Beliau menjabat sebagai asisten profesor dan profesor asosiasi urologi dari tahun 2009 hingga 2016. Beliau adalah anggota Kamar Medis Istanbul, Asosiasi Urologi Turki, Masyarakat Andrologi Turki, dan Asosiasi Ahli Urologi Laut Hitam Timur.
Bidang utama meliputi infertilitas pria (micro-TESE; hasil pada 191 pasien dengan azoospermia non-obstruktif), perbaikan varikokel bedah mikro, bedah prostat (HoLEP, TURP), bedah batu endoskopi (URS, PCNL), dan uro-onkologi. Beliau berbicara bahasa Inggris.
Dr. Paweł Grochowicz, MD, PhD, adalah seorang proktologis dengan pengalaman hampir 40 tahun. Beliau bekerja di Pusat Proktologi Warsawa di Rumah Sakit St. Elizabeth. Beliau menangani wasir, fistula dan abses anus, fisura anus, inkontinensia tinja, dan kista pilonidal. Beliau juga melakukan kolonoskopi dan polipektomi kolorektal.
Dari tahun 1979 hingga 2016, beliau bekerja di Unit Proktologi, Rumah Sakit Solec, sebuah pusat rujukan dan satu-satunya di Polandia. Sejak 2016, beliau bekerja di Pusat Proktologi Warsawa di Rumah Sakit St. Elizabeth. Di sana, beliau mengembangkan dan menerapkan metode baru serta menjalankan pekerjaan diagnostik, rehabilitasi, penelitian, dan pengajaran. Pusat ini merupakan kantor pusat Klub Koloproktologi Polandia.
Peran akademik dan penelitian: Institut Kedokteran Eksperimental dan Klinis, Akademi Ilmu Pengetahuan Polandia (1979–1997). Penerima beasiswa DAAD di LMU Munich (1983–1984). Rumah Sakit John Hunter, Universitas Newcastle, Australia (1989–1996). Di sana, beliau menjabat sebagai Direktur Unit Penelitian Transplantasi dan Pejabat Ilmiah Utama (1991–1996).
Dr. Przemyslaw Ciesielski adalah seorang ahli bedah umum. Ia menyelesaikan spesialisasi pada tahun 2008. Ia lulus dari Universitas Kedokteran Warsawa pada tahun 1999. Ia meraih gelar Doktor Ilmu Kedokteran pada tahun 2010. Disertasinya mengevaluasi pemeriksaan klinis dan rektoskopi untuk mendiagnosis penyakit kolorektal pada pasien dengan peningkatan risiko kanker kolorektal.
Pelatihan proktologi dan kolorektalnya mencakup kursus formal dan fellowship. Ia menyelesaikan Kursus Proktologi di Rumah Sakit St. Rota di Vercelli pada tahun 2021 dan 2022, serta di Cologne pada tahun 2016. Ia menjalani fellowship klinis dalam Bedah Umum di Universitas Kedokteran Wina pada tahun 2014 dan di Universitas Magdeburg pada tahun 2015. Ia menjalani beberapa fellowship di Departemen Proktologi, Rumah Sakit Solec di Warsawa dari tahun 2005 hingga 2013. Ia menghadiri lokakarya bedah kolorektal tingkat lanjut di Poznan dan Lodz. Ia juga menyelesaikan kursus di Rumah Sakit St. Mark di London, termasuk "Frontiers in Colorectal Diseases" dan "Advanced Colorectal Workshop".
Kepala Urologi di Rumah Sakit Swasta Optimed dengan pengalaman 31 tahun pengalaman – Dr. Kirkac memelopori Bedah Batu Ginjal Tertutup di klinik tersebut.
| Peringkat | Dokter | pengalaman | Cocok Untuk | Apa yang Membedakan Mereka | Klinik & Lokasi | Konsultasi |
|---|---|---|---|---|---|---|
| #1 | 10 tahun pengalaman | Bedah testis | Berspesialisasi dalam prosedur urologi invasif minimal dan rekonstruktif. Bersertifikat dengan pelatihan dari Rumah Sakit Siriraj, institusi terkemuka di Thailand. | Thailand | Harga berdasarkan permintaan | |
| #2 | 23 tahun pengalaman | Bedah kanker urologi invasif minimal | Berspesialisasi dalam teknik invasif minimal untuk kanker urologi. Anggota dewan asosiasi uro-onkologi utama dan aktif dalam penelitian kanker kandung kemih. | Turki | dari $215 | |
| #3 | 41 tahun pengalaman | Tumor tulang dan jaringan lunak yang kompleks | Memimpin unit sarkoma terkemuka di Israel dengan pelatihan fellowship di Paris. Anggota fakultas ESMO yang membentuk standar pengobatan sarkoma secara global. | Israel | dari $950 | |
| #4 | 23 tahun pengalaman | Kasus tumor testis yang kompleks | Terkenal dengan tingkat keberhasilan yang tinggi dalam operasi hepatobilier – spesialis dalam kasus organ yang kompleks. Memimpin unit transplantasi di Medical Park Antalya. | Turki | Harga berdasarkan permintaan | |
| #5 | 17 tahun pengalaman | Pengangkatan tumor testis | Pakar dalam bedah urologi invasif minimal dan rekonstruksi kompleks. Memegang fellowship dari Royal College of Surgeons of England dan European Board of Urology. | Siprus | dari €225 | |
| #6 | 20 tahun pengalaman | Pengobatan kanker testis | Pelatihan fellowship di Hacettepe University Cancer Institute dengan pelatihan tambahan di MD Anderson Cancer Center. Berspesialisasi dalam berbagai jenis kanker. | Turki | dari $100 | |
| #7 | 32 tahun pengalaman | Bedah tumor testis | Dokter bedah lulusan Mayo Clinic yang menggunakan teknik invasif minimal. Diakreditasi oleh ERAS-Society untuk protokol pemulihan yang dioptimalkan. Memimpin departemen bedah Teknon dengan pengalaman lebih dari 30 tahun. | Spanyol | Harga berdasarkan permintaan | |
| #8 | 14 tahun pengalaman | Perawatan tumor testis | Memimpin pusat kanker bersertifikat dan berspesialisasi dalam terapi canggih seperti imunoterapi dan perawatan target. Terlibat aktif dalam penelitian biologi molekuler. | Jerman | Harga berdasarkan permintaan | |
| #9 | 2016 tahun pengalaman | Pengangkatan tumor testis | Berspesialisasi dalam bedah onkologi dengan pengalaman luas dalam pengangkatan tumor. Dipromosikan menjadi Profesor Madya karena kontribusi signifikan dalam onkologi. | Turki | Harga berdasarkan permintaan | |
| #10 | 20 tahun pengalaman | Pengobatan kanker testis | Berspesialisasi dalam onkologi urologi dengan fokus pada tumor testis. Terlatih di Universitas Akdeniz – pemimpin dalam penelitian dan pengobatan kanker. | Turki | Harga berdasarkan permintaan |